NASDAQ: CNTA
Centessa Pharmaceuticals plc is a pioneering clinical-stage pharmaceutical company focused on creating innovative medicines. With a diverse pipeline, including treatments for hemophilia, sleep disorders, autoimmune diseases, and pulmonary arterial hypertension, Centessa aims to address complex medical challenges. Key projects include SerpinPC for hemophilia, ORX750 for sleep disorders, and LB101 for enhancing immune response, among others. Founded in 2020 and based in the UK, Centessa is dedicated to advancing healthcare through scientific discovery and development.
Pre-Market Stock Futures: Futures are trading lower this morning after negotiations with Iran failed over the weekend, and President Trump indicated the U.S. will block the Strait of Hormuz. This comes as…
Pre-Market Stock Futures: Futures are trading higher after an explosive rally on Tuesday, sparked by the President’s comments that he wants to end the war soon. While this is hardly the final…
Centessa Pharmaceuticals plc is a pioneering clinical-stage pharmaceutical company focused on creating innovative medicines. With a diverse pipeline, including treatments for hemophilia, sleep disorders, autoimmune diseases, and pulmonary arterial hypertension, Centessa aims to address complex medical challenges.
